Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.
2.

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

Elia J, Borcherding BG, Rapoport JL, Keysor CS.

Psychiatry Res. 1991 Feb;36(2):141-55.

PMID:
2017529
4.

A controlled trial of stimulant medication in children with the fragile X syndrome.

Hagerman RJ, Murphy MA, Wittenberger MD.

Am J Med Genet. 1988 May-Jun;30(1-2):377-92.

PMID:
3052064
5.

An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.

Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N.

Pediatrics. 2006 Jun;117(6):2040-6.

PMID:
16740846
6.

Individual responses to methylphenidate and caffeine in children with minimal brain dysfunction.

Garfinkel BD, Webster CD, Sloman L.

Can Med Assoc J. 1975 Oct 18;113(8):729-32.

7.

Classroom academic performance: improvement with both methylphenidate and dextroamphetamine in ADHD boys.

Elia J, Welsh PA, Gullotta CS, Rapoport JL.

J Child Psychol Psychiatry. 1993 Jul;34(5):785-804.

PMID:
8340445
8.

Responses to methylphenidate and varied doses of caffeine in children with attention deficit disorder.

Garfinkel BD, Webster CD, Sloman L.

Can J Psychiatry. 1981 Oct;26(6):395-401.

PMID:
7028238
9.

Stimulant drug treatment of hyperactivity: biochemical correlates.

Elia J, Borcherding BG, Potter WZ, Mefford IN, Rapoport JL, Keysor CS.

Clin Pharmacol Ther. 1990 Jul;48(1):57-66.

PMID:
2196146
10.

Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.

Gross MD.

Psychosomatics. 1975;16(1):26-7. No abstract available.

PMID:
1101283
11.

Levoamphetamine vs dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating.

Arnold LE, Huestis RD, Smeltzer DJ, Scheib J, Wemmer D, Colner G.

Arch Gen Psychiatry. 1976 Mar;33(3):292-301.

PMID:
769721
12.
13.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
14.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Research Units on Pediatric Psychopharmacology Autism Network.

Arch Gen Psychiatry. 2005 Nov;62(11):1266-74.

PMID:
16275814
15.
16.

Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: a double-blind comparison.

Huestis RD, Arnold LE, Smeltzer DJ.

Am J Psychiatry. 1975 Aug;132(8):868-70.

PMID:
1096645
17.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
18.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
19.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

20.

Stimulant drugs for severe hyperactivity in childhood.

[No authors listed]

Drug Ther Bull. 2001 Jul;39(7):52-4. Review.

PMID:
11471516

Supplemental Content

Support Center